Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00795912Phase 4Completed
Phase 4, randomised, open-label trial of atorvastatin in heart failure (HF) (2 arms), sponsored by St. Vincent's University Hospital. Primary endpoints: High Sensitivity C-Reactive Protein at 6 months, Tumor Necrosis Factor alpha at 6 months and 1 more. Started May 2003; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00795912.